subscribeSubscribe
AstraZeneca beats revenue, profit estimates on resilient demand

AstraZeneca beats revenue, profit estimates on resilient demand
REUTERS
25 Apr 2024
Share Share
AstraZeneca cries havoc over CKD`s hit on economies, environment

AstraZeneca cries havoc over CKD`s hit on economies, environment
Nick Paul Taylor FIERCE PHARMA
15 Apr 2024
Share Share
TheracosBio`s BRENZAVVY® Non-Inferior To Dapagliflozin

TheracosBio`s BRENZAVVY® Non-Inferior To Dapagliflozin
BUSINESSWIRE
12 Apr 2024
Share Share
Zydus Pharma`s Generic Dapagliflozin Receives Approval in the U.S.

Zydus Pharma`s Generic Dapagliflozin Receives Approval in the U.S.
FDA
28 Feb 2024
Share Share
Zibotentan/dapagliflozin combination showed albuminuria reduction in patients

Zibotentan/dapagliflozin combination showed albuminuria reduction in patients
BUSINESSWIRE
03 Nov 2023
Share Share
Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin

Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin
INDIAN PHARMA POST
18 Oct 2023
Share Share
Forxiga met primary endpoint in T2NOW Phase III trial

Forxiga met primary endpoint in T2NOW Phase III trial
PRESS RELEASE
04 Oct 2023
Share Share
AZ`s Dobber talks SGTL2, GLP-1 clash in heart failure

AZ`s Dobber talks SGTL2, GLP-1 clash in heart failure
Angus Liu FIERCE PHARMA
30 Aug 2023
Share Share
At ESC, AstraZeneca shows Farxiga`s benefits across indications

At ESC, AstraZeneca shows Farxiga`s benefits across indications
Kevin Dunleavy FIERCE PHARMA
28 Aug 2023
Share Share
Forxiga approved in China to reduce the risk of cardiovascular death

Forxiga approved in China to reduce the risk of cardiovascular death
PRESS RELEASE
18 Aug 2023
Share Share